Delivery Order SPE2DB22D3016-SPE2DB25FAYE4

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562549359 - Triamterene 50 mg capsules, 100-count bottles. The award has a ceiling value of $9,310.29 and a completion date of October 23, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,107,803 units of the medication Triamterene 50 mg capsule in 100-count bottles. The award has a ceiling value of $4,580.60 and a period of performance through May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 50 mg triamterene capsules to support military treatment programs and facilities worldwide. The contract has a ceiling value of $9,899.72 and a completion date of September 16, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,756.59 firm fixed-price delivery order is for the supply of 4566748373 TRIAMTERENE 50 MG CAPSULE 100S, with a completion date of December 18, 2024. The contract is not designated with any set-aside requirements, indicating open competition. In addition to this specific delivery order, AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.79 firm fixed-price contract is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a pharmaceutical product, with a performance period through June 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corporation is a $4,903.30 Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of Triamterene 50 mg capsules, a pharmaceutical product, to support federal healthcare programs and services. The contract has a firm fixed price and an ultimate completion date of September 12, 2024. This award is part of Amerisourcebergen's extensive federal contracting...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG CP 90S, a pharmaceutical product, with a ceiling value of $3,270.73 and a completion date of May 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $2,518.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract involves the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages, with a performance period ending on May 15, 2025. The contract is a firm-fixed price delivery order and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,952.91, is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,398.80, is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAYE4
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of the medication Triamterene 50 mg, with a ceiling value of $1,061.79 and a completion date of June 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/2/25, 9:43 AM